Sign Up to like & get
recommendations!
1
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-215647
Abstract: We have read with interest the results of the MYCYC trial showing that mycophenolate mofetil (MMF) is not inferior to intravenous cyclophosphamide (CYC) in achieving a primary remission in the treatment of ANCA-associated vasculitides (AAV).1…
read more here.
Keywords:
mofetil step;
treatment anca;
mycophenolate mofetil;
anca associated ... See more keywords